BBO-8520
Phase 1- Indications
- KRAS G12C mutant non-small cell lung cancer
Company intelligence / Profile preview
Helix Pharma
Karachi, Sindh, Pakistanhelix-ph.com ↗
- Ownership
- Private
- Employees
- ~1000
- Development stage
- Phase 1
01
Overview
Helix Pharma manufactures and markets a broad portfolio of commercialized pharmaceutical products and medicines across various therapeutic areas. There is no public evidence of proprietary clinical programs or novel late-stage investigational drugs.
- Therapeutic areas
- PsychiatryGastroenterologyInfectious DiseasesPulmonologyOncologyOphthalmologyCardiovascularWomen's Health
- Modalities
- Small molecule
- Industry
- Contract Manufacturing Organization
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Takeda PharmaceuticalCelon Laboratories (India)Reliance Life Sciences (India)
Beyond the preview
Go deeper on Helix Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Helix Pharma.